TABLE OF CONTENTS
Volume 26, Issue 34 (26 July 2007)
Original Articles
Distinct roles of first exon variants of the tumor-suppressor Patched1 in Hedgehog signaling
T Shimokawa, J Svärd, K Heby-Henricson, S Teglund, R Toftgård and P G Zaphiropoulos
Oncogene 26: 4889-4896; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210301
Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2
S F Winter, V D Acevedo, R D Gangula, K W Freeman, D M Spencer and N M Greenberg
Oncogene 26: 4897-4907; advance online publication, February 12, 2007; doi:10.1038/sj.onc.1210288
The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein–Barr virus LMP2A membrane protein
L V Matskova, C Helmstetter, R J Ingham, G Gish, C K Lindholm, I Ernberg, T Pawson and G Winberg
Oncogene 26: 4908-4917; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210298
PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion
X Liu, Y Hu, C Hao, S A Rempel and K Ye
Oncogene 26: 4918-4927; advance online publication, February 12, 2007; doi:10.1038/sj.onc.1210290
p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates 
-catenin pathway
P-C Hsieh, J-C Chang, W-T Sun, S-C Hsieh, M-C Wang and F-F Wang
Oncogene 26: 4928-4940; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210304
Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A
L C Waters, V Veverka, M Böhm, T Schmedt, P T Choong, F W Muskett, K-H Klempnauer and M D Carr
Oncogene 26: 4941-4950; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210305
Role of Gab2 in mammary tumorigenesis and metastasis
Y Ke, D Wu, F Princen, T Nguyen, Y Pang, J Lesperance, W J Muller, R G Oshima and G-S Feng
Oncogene 26: 4951-4960; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210315
Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro
X He, M Pool, K M Darcy, S B Lim, N Auersperg, J S Coon and W T Beck
Oncogene 26: 4961-4968; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210307
Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance
J Staub, J Chien, Y Pan, X Qian, K Narita, G Aletti, M Scheerer, L R Roberts, J Molina and V Shridhar
Oncogene 26: 4969-4978; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210300
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen
D Bubman, I Guasparri and E Cesarman
Oncogene 26: 4979-4986; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210299
Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases
A Hausherr, R Tavares, M Schäffer, A Obermeier, C Miksch, O Mitina, J Ellwart, M Hallek and G Krause
Oncogene 26: 4987-4998; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210306
Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme
L Lalier, P-F Cartron, F Pedelaborde, C Olivier, D Loussouarn, S A Martin, K Meflah, J Menanteau and F M Vallette
Oncogene 26: 4999-5009; advance online publication, March 19, 2007; doi:10.1038/sj.onc.1210303
Short Communications
Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q
B Tews, P Roerig, C Hartmann, M Hahn, J Felsberg, B Blaschke, M Sabel, A Kunitz, G Toedt, K Neben, A Benner, A von Deimling, G Reifenberger and P Lichter
Oncogene 26: 5010-5016; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210297
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
C Welch, Y Chen and R L Stallings
Oncogene 26: 5017-5022; advance online publication, February 12, 2007; doi:10.1038/sj.onc.1210293
Oncogenomics
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272
Y Minami, T Shimamura, K Shah, T LaFramboise, K A Glatt, E Liniker, C L Borgman, H J Haringsma, W Feng, B A Weir, A M Lowell, J C Lee, J Wolf, G I Shapiro, K-K Wong, M Meyerson and R K Thomas
Oncogene 26: 5023-5027; advance online publication, February 19, 2007; doi:10.1038/sj.onc.1210292
